The risks and consequences of opioid misuse

dc.contributor.advisorZollinger, Terrel W.
dc.contributor.advisorSteele, Gregory K.
dc.contributor.authorGreene, Marion Siegrid
dc.contributor.otherYiannoutsos, Constantin T.
dc.contributor.otherChambers, R. Andrew
dc.contributor.otherVest, Joshua R.
dc.contributor.otherWright, Eric R.
dc.date.accessioned2018-08-13T13:29:44Z
dc.date.available2020-08-09T09:30:11Z
dc.date.issued2018-05-22
dc.degree.date2018en_US
dc.degree.disciplineRichard N. Fairbanks School of Public Health
dc.degree.grantorIndiana Universityen_US
dc.degree.levelPh.D.en_US
dc.descriptionIndiana University-Purdue University Indianapolis (IUPUI)en_US
dc.description.abstractOpioid misuse and addiction has been widely identified as a public health problem, contributing substantially to the nation’s morbidity and mortality. Over the past two decades, misuse of prescription opioids pain relievers has substantially increased; heroin use has resurged; and, more recently, abuse of high-potency synthetic opioids such as fentanyl have fueled the epidemic. Nearly 12 million Americans (or 4.4%) aged 12 and older misused some type of opioid (prescribed or illegal) in the past year. Furthermore, the percentage of substance use treatment admissions attributable to opioids nearly doubled in the U.S., from 20.8% in 2000 to 40.5% in 2015. The purpose of this dissertation research was to investigate associations between prescription pain reliever use and subsequent negative health outcomes, including opioid misuse or addiction, and neonatal abstinence syndrome. This research focused on three specific aims: Specific Aim #1: Examine heroin use among Indiana’s substance use treatment population to measure the extent, trends, and patterns of use, as well as to assess the relationship between prescription opioids and subsequent heroin use; Specific Aim #2: Analyze 2014 INSPECT (Indiana’s prescription drug monitoring program) data to identify factors that increase patients’ likelihood to engage in opioidrelated risk behaviors; and Specific Aim #3: Review U.S. trends in neonatal abstinence syndrome (NAS) incidence from 2008-2014, measure regional variability, and identify personal and environmental risk factors associated with NAS.en_US
dc.description.embargo2020-08-09
dc.identifier.doi10.7912/C2MS9C
dc.identifier.urihttps://hdl.handle.net/1805/17108
dc.identifier.urihttps://doi.org/10.7912/C2MS9C
dc.identifier.urihttp://dx.doi.org/10.7912/C2/2834
dc.language.isoen_USen_US
dc.subjectAddictionen_US
dc.subjectNeonatal abstinence syndromeen_US
dc.subjectOpioidsen_US
dc.subjectPrescription drug monitoring programsen_US
dc.subjectSubstance use treatmenten_US
dc.titleThe risks and consequences of opioid misuseen_US
dc.typeDissertation
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Greene_iupui_0104D_10295.pdf
Size:
538.25 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: